Combination of ablative fractional laser and daylight-mediated photodynamic therapy for actinic keratosis in organ transplant recipients - A randomized controlled trial

British Journal of Dermatology

Volumn 172, Issue 2, 2015, Pages 467-474

  Togsverd Bo, K ^a   Lei, U ^a   Erlendsson, A M ^a   Taudorf, E H ^a   Philipsen, P A ^a   Wulf, H C ^a   Skov, L ^a   Haedersdal M ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER; AMINOLEVULINIC ACID; METHYL 5-AMINOLEVULINATE; PHOTOSENSITIZING AGENT;

ABLATION THERAPY; ABLATIVE FRACTIONAL LASER; ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; CAMERA; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHEMA; FEMALE; GRAFT RECIPIENT; HUMAN; HYPOPIGMENTATION; INTERMETHOD COMPARISON; IRRADIATION; LASER; MALE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RED LIGHT; SUNLIGHT; TREATMENT DURATION; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; COMPARATIVE STUDY; KERATOSIS, ACTINIC; LOW LEVEL LASER THERAPY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PAIN; PHOTOCHEMOTHERAPY; PHOTOSENSITIVITY DISORDERS; PROCEDURES; TREATMENT OUTCOME;

AGED; AMINOLEVULINIC ACID; COMBINED MODALITY THERAPY; FEMALE; HUMANS; KERATOSIS, ACTINIC; LASER THERAPY; MALE; MIDDLE AGED; PAIN; PHOTOCHEMOTHERAPY; PHOTOSENSITIVITY DISORDERS; PHOTOSENSITIZING AGENTS; TRANSPLANT RECIPIENTS; TREATMENT OUTCOME;

EID: 84922939646     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.13222     Document Type: Article

References (35)

1. Zwald FO, Brown M,. Skin cancer in solid organ transplant recipients: advances in therapy and management: part I. Epidemiology of skin cancer in solid organ transplant recipients. J Am Acad Dermatol 2011; 65: 253-61.
2. Engels EA, Pfeiffer RM, Fraumeni JF Jr, et al,. Spectrum of cancer risk among US solid organ transplant recipients. JAMA 2011; 306: 1891-901.
3. Jensen AO, Svaerke C, Farkas D, et al,. Skin cancer risk among solid organ recipients: a nationwide cohort study in Denmark. Acta Derm Venereol 2010; 90: 474-9.
4. Krynitz B, Edgren G, Lindelof B, et al,. Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008-a Swedish population-based study. Int J Cancer 2013; 132: 1429-38.
5. Ramsay HM, Fryer AA, Reece S, et al,. Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipients. Am J Kidney Dis 2000; 36: 167-76.
6. Basset-Seguin N, Baumann CK, Gerritsen MJ, et al,. Photodynamic therapy for actinic keratosis in organ transplant patients. J Eur Acad Dermatol Venereol 2013; 27: 57-66.
7. Braathen LR, Morton CA, Basset-Seguin N, et al,. Photodynamic therapy for skin field cancerization: an international consensus. International Society for Photodynamic Therapy in Dermatology. J Eur Acad Dermatol Venereol 2012; 26: 1063-6.
8. Zwald FO, Brown M,. Skin cancer in solid organ transplant recipients: advances in therapy and management: part II. Management of skin cancer in solid organ transplant recipients. J Am Acad Dermatol 2011; 65: 263-79.
9. Wennberg AM, Stenquist B, Stockfleth E, et al,. Photodynamic therapy with methyl aminolevulinate for prevention of new skin lesions in transplant recipients: a randomized study. Transplantation 2008; 86: 423-9.
10. Szeimies RM, Torezan L, Niwa A, et al,. Clinical, histopathological and immunohistochemical assessment of human skin field cancerization before and after photodynamic therapy. Br J Dermatol 2012; 167: 150-9.
11. Tyrrell JS, Campbell SM, Curnow A,. The relationship between protoporphyrin IX photobleaching during real-time dermatological methyl-aminolevulinate photodynamic therapy (MAL-PDT) and subsequent clinical outcome. Lasers Surg Med 2010; 42: 613-19.
12. Dragieva G, Hafner J, Dummer R, et al,. Topical photodynamic therapy in the treatment of actinic keratoses and Bowen's disease in transplant recipients. Transplantation 2004; 77: 115-21.
13. Halldin CB, Paoli J, Sandberg C, et al,. Nerve blocks enable adequate pain relief during topical photodynamic therapy of field cancerization on the forehead and scalp. Br J Dermatol 2009; 160: 795-800.
14. Wiegell SR, Haedersdal M, Philipsen PA, et al,. Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single-blinded study. Br J Dermatol 2008; 158: 740-6.
15. Wiegell SR, Haedersdal M, Eriksen P, Wulf HC,. Photodynamic therapy of actinic keratoses with 8% and 16% methyl aminolaevulinate and home-based daylight exposure: a double-blinded randomized clinical trial. Br J Dermatol 2009; 160: 1308-14.
16. Wiegell SR, Fabricius S, Gniadecka M, et al,. Daylight-mediated photodynamic therapy of moderate to thick actinic keratoses of the face and scalp: a randomized multicentre study. Br J Dermatol 2012; 166: 1327-32.
17. Wiegell SR, Fabricius S, Stender IM, et al,. A randomized, multicentre study of directed daylight exposure times of 1(1/2) vs. 2(1/2) h in daylight-mediated photodynamic therapy with methyl aminolaevulinate in patients with multiple thin actinic keratoses of the face and scalp. Br J Dermatol 2011; 164: 1083-90.
18. Wulf HC, Pavel S, Stender I, et al,. Topical photodynamic therapy for prevention of new skin lesions in renal transplant recipients. Acta Derm Venereol 2006; 86: 25-8.
19. Dragieva G, Prinz BM, Hafner J, et al,. A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients. Br J Dermatol 2004; 151: 196-200.
20. Piaserico S, Belloni Fortina A, Rigotti P, et al,. Topical photodynamic therapy of actinic keratosis in renal transplant recipients. Transplant Proc 2007; 39: 1847-50.
21. ®)-PDT in actinic keratosis of the face and scalp. Acta Derm Venereol 2005; 85: 424-8.
22. Togsverd-Bo K, Haak CS, Thaysen-Petersen D, et al,. Intensified photodynamic therapy of actinic keratoses with fractional CO2 laser: a randomized clinical trial. Br J Dermatol 2012; 166: 1262-9.
23. 2 laser-assisted photodynamic therapy vs. laser alone for organ transplant recipients with multiple actinic keratoses and wart-like lesions: a randomized half-side comparative trial on dorsal hands. Br J Dermatol 2013; 169: 1087-92.
24. Lippert J, Smucler R, Vlk M,. Fractional carbon dioxide laser improves nodular basal cell carcinoma treatment with photodynamic therapy with methyl 5-aminolevulinate. Dermatol Surg 2013; 39: 1202-8.
25. Ko DY, Kim KH, Song KH,. A randomized trial comparing methyl aminolevulinate photodynamic therapy with and without Er:YAG ablative fractional laser treatment in Asian patients with lower extremity Bowen disease: results from a 12-month follow-up. Br J Dermatol 2014; 170: 165-72.
26. Manstein D, Herron GS, Sink RK, et al,. Fractional photothermolysis: a new concept for cutaneous remodeling using microscopic patterns of thermal injury. Lasers Surg Med 2004; 34: 426-38.
27. Haedersdal M, Sakamoto FH, Farinelli WA, et al,. Fractional CO(2) laser-assisted drug delivery. Lasers Surg Med 2010; 42: 113-22.
28. Haedersdal M, Katsnelson J, Sakamoto FH, et al,. Enhanced uptake and photoactivation of topical methyl aminolevulinate after fractional CO2 laser pretreatment. Lasers Surg Med 2011; 43: 804-13.
29. Forster B, Klein A, Szeimies RM, Maisch T,. Penetration enhancement of two topical 5-aminolaevulinic acid formulations for photodynamic therapy by erbium:YAG laser ablation of the stratum corneum: continuous versus fractional ablation. Exp Dermatol 2010; 19: 806-12.
30. Olsen EA, Abernethy ML, Kulp-Shorten C, et al,. A double-blind, vehicle-controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neck. J Am Acad Dermatol 1991; 24: 738-43.
31. Wiegell SR, Wulf HC, Szeimies RM, et al,. Daylight photodynamic therapy for actinic keratosis: an international consensus: International Society for Photodynamic Therapy in Dermatology. J Eur Acad Dermatol Venereol 2012; 26: 673-9.
32. Taudorf EH, Haak CS, Erlendsson AM, et al,. Fractional ablative erbium YAG laser: histological characterization of relationship between laser settings and micropore dimensions. Lasers Surg Med 2014; 46: 281-9.
33. Skovbølling Haak C, Illes M, Paasch U, Hædersdal M,. Histological evaluation of vertical laser channels from ablative fractional resurfacing: an ex vivo pig skin model. Lasers Med Sci 2011; 26: 465-71.
34. Togsverd-Bo K, Paasch U, Haak CS, Hædersdal M,. Lesion dimensions following ablative fractional laser treatment in non-melanoma skin cancer and premalignant lesions. Lasers Med Sci 2012; 27: 675-9.
35. Wiegell SR, Heydenreich J, Fabricius S, Wulf HC,. Continuous ultra-low-intensity artificial daylight is not as effective as red LED light in photodynamic therapy of multiple actinic keratosis. Photodermatol Photoimmunol Photomed 2011; 27: 280-6.